arrow_back Back Filing freshness 10-Q Q1 FY2027 SEC EDGAR

PETMED EXPRESS INC

PETS
$1.55 ▼ -0.02 (-1.27%) at close
Healthcare ·Retail-Drug Stores and Proprietary Stores ·USRetail-Drug Stores and Proprietary Stores
67 Visible periods
30 Metrics
Peer-ranked Benchmarks
Price Chart
9
Health
Poor
Bearish
auto_awesome

Analytical Summary

PETMED EXPRESS INC faces fundamental challenges with weakness in Return on Common Equity (%) and Profit Margin (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $33.6M
Dividend Yield
Revenue Growth -19.9%
Op. Margin -15.2%
ROIC -27.2%
FCF / Share $-0.38
Trailing P/E
Price / Book 1.5x
FCF Yield
Debt / Equity
info Valuation on last close. End-of-day price, Sep 23, 2026.

67-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$41.02M
↓ -19.9%
Net Income Profit after all expenses
$-6.14M
↑ +82.0%
Operating Margin Operating profit as % of sales
-15.2%
↓ -14.3% 2th
FCF / Share Free cash flow per share
$-0.38
↑ +41.2%
trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Operating Margin (%)Operating Margin (%) is in the bottom quartile
  • Profit Margin (%)Profit Margin (%) is in the bottom quartile
  • Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Profitability
3
Returns
2
Cash Quality
40

Dividend History

Dividend / share · sourced from SEC filings
$0.00 Latest / share

bar_chart Data from SEC EDGAR XBRL filings

Synced yesterday 18 years · 67 quarters